Editorial: Focus on Alzheimer's Disease and Related Disorders
J Clin Psychiatry 2005;66(7):816-817
© Copyright 2014 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.
The Journal of Clinical Psychiatry
to informing its readers about the progress now being made in the scientific understanding, diagnosis, treatment,
and prevention of Alzheimer’s disease. With this
commitment in mind, the Journal
announces its plan to
publish from time to time special articles and sections as
part of a “Focus on Alzheimer’s Disease and Related Disorders”
series. To inaugurate the series, this issue includes
a report in which Andreas Papassotiropoulos, M.D., and
his colleagues implicate a cluster of cholesterol-related
genes in the vulnerability to late-onset Alzheimer’s disease
and propose for subsequent research studies a
cholesterol-related genetic risk score to help characterize
an individual’s vulnerability to this disorder.